CUSIP 75974E103COMQ4 2025
21 filings · latest Jan 21, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Torren Management, LLC | 504 | $1.5K |
| 4 | Sep 26, 2024 | Tang Capital Partners LP | 13G | 8.8% | 2.95M | SEC |
| 5 | May 21, 2024 | Bml Investment Partners, L.P. | 13G/A | 8.0% | 2.67M | SEC |
| 6 | May 8, 2024 | New Enterprise Associates 15, L.P. | 13D/A | 14.3% | 4.79M | SEC |
| 7 | Feb 5, 2024 | Octagon Capital Advisors LP | 13G | 6.8% | 2.25M | SEC |
| 8 | Jan 17, 2024 | Bml Investment Partners, L.P. | 13G | 4.1% | 1.36M | SEC |
| 9 | Dec 26, 2023 | Tang Capital Partners LP | 13D | 10.0% | 3.33M | SEC |
| 10 | Dec 15, 2023 | Novo Holdings A/S | 13D/A | — | — | SEC |
See the full Schedule 13D/13G history for Reneo Pharmaceuticals Inc.
Unlock full history